Implementing International Standards of Practice in A Low Resource Country by Blended Training Modules to Improve Stroke Care
NCT ID: NCT04995146
Last Updated: 2021-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2021-01-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Essential Acute Stroke Care in Low Resource Settings: a Pilot studY
NCT04157231
Chinese Acute Ischemic Stroke Treatment Outcome Registry
NCT02470624
The Neuroprotective Effect of Remote Ischemic Preconditioning on Ischemic Cerebral Vascular Disease
NCT01321749
Intervention to Bridge the Evidence-based Gap in Stroke Care Quality
NCT02212912
Ventilation Modalities and Acute Ischemic Stroke
NCT05323266
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: The project will be conducted across four hospitals in Pakistan in three phases. First stage will include retrospective collection of data for the preceding 4 weeks from start. In stage II, 3 months data will be collected before implementation of core measures. The stepwise training of staff will begin simultaneously, and data will continue to be collected. In stage III by the end of 3 months of stage II, core measures will be implemented as standard of care and patients will be enrolled for another 3 months. Outcomes measures will be successful implementation of the stroke care model as measured by survey done at the end and patient outcomes including in-hospital complication rates, length of hospital stay, patient and caregiver education, mRS at 3 months after discharge, post discharge complications and re-stroke rate. Data will be compared against published data from Pakistan and between patients in the first and last 3 months of the project. Statistical analyses will include appropriate mixed-effects multivariate regression models (i.e., linear and logistic) to model the relationship between clinical measures and patient safety. Degree of correlation across each symptom predictor will be measured. This study will not involve thrombolytic therapy or thrombectomy. However, the study will not provide any hindrance to implementation of such therapy and will not include such patients in analysis.
Discussion: At least one third of stroke survivors in Pakistan die due to recurrent vascular events and complications of stroke in absence of core measures. Prevention practices and stroke care are significantly underutilized in low- and middle-income countries but can be improved most efficiently by improving care delivering process without additional burden on resources by following American Heart Association "Get With The Guidelines" Stroke (GWTG-Stroke) program, Royal College of Physicians UK and European Guidelines, regardless of thrombolysis or thrombectomy. This feasibility study aims to develop a multidisciplinary comprehensive stroke team model with gradual integration of staff training, nursing care, therapy and patient education.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Retrospective 3 months cohort (admitted stroke patients)
Clinical stroke extended management pathway
1. Extracranial imaging
2. ECG in 2-7 days
3. DVT prophylaxis
4. Stroke educational material for patient and family Removal of Foley's catheter and start bladder management
5. Discharged on: Antithrombotic therapy OR Anticoagulation therapy▸ Antihypertensives ▸ Statins/cholesterol lower agent ▸ Antidiabetic agent
6. Fasting lipid profile, HbA1c
7. Holter monitor
8. Specialized workup for young stroke
9. PFO Study, MES Study
10. Referral to: ▸ Rehabilitation specialist ▸ Speech therapist ▸ Dietician ▸ Occupational therapist ▸ Medical team
11. Follow-up: CTA, CT angiography; HbA1c, glycated haemoglobin; MRA, MR angiography
12. Follow-up plan and 90 day mRS
Prospective pre-implementation "standard of core care quality measures" cohort
Clinical stroke extended management pathway
1. Extracranial imaging
2. ECG in 2-7 days
3. DVT prophylaxis
4. Stroke educational material for patient and family Removal of Foley's catheter and start bladder management
5. Discharged on: Antithrombotic therapy OR Anticoagulation therapy▸ Antihypertensives ▸ Statins/cholesterol lower agent ▸ Antidiabetic agent
6. Fasting lipid profile, HbA1c
7. Holter monitor
8. Specialized workup for young stroke
9. PFO Study, MES Study
10. Referral to: ▸ Rehabilitation specialist ▸ Speech therapist ▸ Dietician ▸ Occupational therapist ▸ Medical team
11. Follow-up: CTA, CT angiography; HbA1c, glycated haemoglobin; MRA, MR angiography
12. Follow-up plan and 90 day mRS
Prospective post-implementation "standard of core care quality measures" cohort
Clinical stroke extended management pathway
1. Extracranial imaging
2. ECG in 2-7 days
3. DVT prophylaxis
4. Stroke educational material for patient and family Removal of Foley's catheter and start bladder management
5. Discharged on: Antithrombotic therapy OR Anticoagulation therapy▸ Antihypertensives ▸ Statins/cholesterol lower agent ▸ Antidiabetic agent
6. Fasting lipid profile, HbA1c
7. Holter monitor
8. Specialized workup for young stroke
9. PFO Study, MES Study
10. Referral to: ▸ Rehabilitation specialist ▸ Speech therapist ▸ Dietician ▸ Occupational therapist ▸ Medical team
11. Follow-up: CTA, CT angiography; HbA1c, glycated haemoglobin; MRA, MR angiography
12. Follow-up plan and 90 day mRS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical stroke extended management pathway
1. Extracranial imaging
2. ECG in 2-7 days
3. DVT prophylaxis
4. Stroke educational material for patient and family Removal of Foley's catheter and start bladder management
5. Discharged on: Antithrombotic therapy OR Anticoagulation therapy▸ Antihypertensives ▸ Statins/cholesterol lower agent ▸ Antidiabetic agent
6. Fasting lipid profile, HbA1c
7. Holter monitor
8. Specialized workup for young stroke
9. PFO Study, MES Study
10. Referral to: ▸ Rehabilitation specialist ▸ Speech therapist ▸ Dietician ▸ Occupational therapist ▸ Medical team
11. Follow-up: CTA, CT angiography; HbA1c, glycated haemoglobin; MRA, MR angiography
12. Follow-up plan and 90 day mRS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
\-
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Foundation University Islamabad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fauji Foundation Hospital
Rawalpindi, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FUI/CTR/2020/8
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.